Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.drudis.2020.10.009

http://scihub22266oqcxt.onion/10.1016/j.drudis.2020.10.009
suck pdf from google scholar
33099021!7577316!33099021
unlimited free pdf from europmc33099021    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33099021      Drug+Discov+Today 2021 ; 26 (1): 122-137
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Advances in the development of entry inhibitors for sialic-acid-targeting viruses #MMPMID33099021
  • Heida R; Bhide YC; Gasbarri M; Kocabiyik O; Stellacci F; Huckriede ALW; Hinrichs WLJ; Frijlink HW
  • Drug Discov Today 2021[Jan]; 26 (1): 122-137 PMID33099021show ga
  • Over the past decades, several antiviral drugs have been developed to treat a range of infections. Yet the number of treatable viral infections is still limited, and resistance to current drug regimens is an ever-growing problem. Therefore, additional strategies are needed to provide a rapid cure for infected individuals. An interesting target for antiviral drugs is the process of viral attachment and entry into the cell. Although most viruses use distinct host receptors for attachment to the target cell, some viruses share receptors, of which sialic acids are a common example. This review aims to give an update on entry inhibitors for a range of sialic-acid-targeting viruses and provides insight into the prospects for those with broad-spectrum potential.
  • |*N-Acetylneuraminic Acid/antagonists & inhibitors/metabolism[MESH]
  • |Antiviral Agents/*pharmacology[MESH]
  • |Drug Discovery[MESH]
  • |Humans[MESH]
  • |Receptors, Virus/antagonists & inhibitors[MESH]
  • |Virus Diseases/classification/*drug therapy[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box